SG73510A1 - Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same - Google Patents
Methods for producing enhanced antigenic enteric bacteria and vaccines comprising sameInfo
- Publication number
- SG73510A1 SG73510A1 SG1998000819A SG1998000819A SG73510A1 SG 73510 A1 SG73510 A1 SG 73510A1 SG 1998000819 A SG1998000819 A SG 1998000819A SG 1998000819 A SG1998000819 A SG 1998000819A SG 73510 A1 SG73510 A1 SG 73510A1
- Authority
- SG
- Singapore
- Prior art keywords
- vaccines
- methods
- same
- enteric bacteria
- producing enhanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31840994A | 1994-10-05 | 1994-10-05 | |
| US08/538,545 US5679564A (en) | 1994-10-05 | 1995-10-03 | Methods for producing enhanced antigenic campylobacter bacteria and vaccines |
| US08/538,543 US5681736A (en) | 1994-10-05 | 1995-10-03 | Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG73510A1 true SG73510A1 (en) | 2000-06-20 |
Family
ID=27405987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1998000819A SG73510A1 (en) | 1994-10-05 | 1995-10-04 | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| SG1998000815A SG73509A1 (en) | 1994-10-05 | 1995-10-04 | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1998000815A SG73509A1 (en) | 1994-10-05 | 1995-10-04 | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0804542A4 (en) |
| JP (1) | JP3394047B2 (en) |
| CN (1) | CN1168693A (en) |
| AU (1) | AU704283B2 (en) |
| BR (1) | BR9509276A (en) |
| CA (1) | CA2202027A1 (en) |
| CZ (1) | CZ104397A3 (en) |
| FI (1) | FI971403A (en) |
| HU (1) | HUT77876A (en) |
| IL (1) | IL115521A0 (en) |
| MX (1) | MX9702431A (en) |
| NO (1) | NO971519L (en) |
| NZ (1) | NZ295907A (en) |
| PL (1) | PL182700B1 (en) |
| SG (2) | SG73510A1 (en) |
| WO (1) | WO1996011258A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT77574A (en) * | 1994-10-05 | 1998-06-29 | Antex Biologics Inc. | Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| EP2327720A1 (en) * | 2003-05-30 | 2011-06-01 | Intercell AG | Enterococcus antigens |
| WO2007108903A2 (en) * | 2006-03-17 | 2007-09-27 | Cerebus Biologicals, Inc. | Campylobacter vaccines and methods of use |
| JP5398527B2 (en) * | 2007-05-28 | 2014-01-29 | 北里第一三共ワクチン株式会社 | Parapertussis whole cell vaccine composition |
| CN107513553B (en) * | 2017-09-18 | 2021-05-18 | 江南大学 | Method for screening lactobacillus with antagonistic campylobacter jejuni infection function |
| CN109633151B (en) * | 2018-12-26 | 2022-03-11 | 西北农林科技大学 | Salmonella enteritidis detection method, test strip and application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0533492A3 (en) * | 1991-09-18 | 1994-08-10 | Amgen Inc | A hepatitis b vaccine formulation incorporating a bile acid salt |
-
1995
- 1995-10-04 EP EP95937449A patent/EP0804542A4/en not_active Withdrawn
- 1995-10-04 CA CA002202027A patent/CA2202027A1/en not_active Abandoned
- 1995-10-04 BR BR9509276A patent/BR9509276A/en not_active Application Discontinuation
- 1995-10-04 WO PCT/US1995/013196 patent/WO1996011258A1/en not_active Application Discontinuation
- 1995-10-04 JP JP51271696A patent/JP3394047B2/en not_active Expired - Fee Related
- 1995-10-04 CN CN95196589A patent/CN1168693A/en active Pending
- 1995-10-04 SG SG1998000819A patent/SG73510A1/en unknown
- 1995-10-04 AU AU39561/95A patent/AU704283B2/en not_active Ceased
- 1995-10-04 MX MX9702431A patent/MX9702431A/en not_active IP Right Cessation
- 1995-10-04 PL PL95319580A patent/PL182700B1/en not_active IP Right Cessation
- 1995-10-04 NZ NZ295907A patent/NZ295907A/en unknown
- 1995-10-04 CZ CZ971043A patent/CZ104397A3/en unknown
- 1995-10-04 SG SG1998000815A patent/SG73509A1/en unknown
- 1995-10-04 HU HU9702303A patent/HUT77876A/en unknown
- 1995-10-05 IL IL11552195A patent/IL115521A0/en unknown
-
1997
- 1997-04-03 NO NO971519A patent/NO971519L/en not_active Application Discontinuation
- 1997-04-04 FI FI971403A patent/FI971403A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3956195A (en) | 1996-05-02 |
| PL182700B1 (en) | 2002-02-28 |
| BR9509276A (en) | 1997-11-18 |
| CA2202027A1 (en) | 1996-04-18 |
| FI971403A0 (en) | 1997-04-04 |
| NZ295907A (en) | 1999-04-29 |
| EP0804542A1 (en) | 1997-11-05 |
| JPH10507347A (en) | 1998-07-21 |
| CZ104397A3 (en) | 1998-06-17 |
| HUT77876A (en) | 1998-09-28 |
| NO971519L (en) | 1997-05-27 |
| WO1996011258A1 (en) | 1996-04-18 |
| FI971403A (en) | 1997-06-04 |
| IL115521A0 (en) | 1996-06-18 |
| EP0804542A4 (en) | 1998-10-28 |
| SG73509A1 (en) | 2000-06-20 |
| PL319580A1 (en) | 1997-08-18 |
| JP3394047B2 (en) | 2003-04-07 |
| NO971519D0 (en) | 1997-04-03 |
| MX9702431A (en) | 1998-05-31 |
| AU704283B2 (en) | 1999-04-15 |
| CN1168693A (en) | 1997-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5584086B1 (en) | Therapeutic pillow and method | |
| HU9602310D0 (en) | Urease-based vaccine and treatment for helicobacter infection | |
| EP0555366A4 (en) | Bacterial attenuation method and vaccine | |
| EP0769963A4 (en) | Polyepitope vaccines | |
| ZA965459B (en) | Vaccines | |
| HUP0000318A3 (en) | Tumor vaccine and process for the preparation thereof | |
| IL129530A0 (en) | Acellular pertussis vaccine with diphtheria and tetanus-toxoids | |
| GB9410922D0 (en) | Vaccines | |
| HUP9701586A3 (en) | Improved inactivated vaccines | |
| EP0705673A3 (en) | Medical articles and method therefor | |
| SG73510A1 (en) | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same | |
| EP0453497A4 (en) | Treatment methods and vaccines | |
| PL314303A1 (en) | Vaccine designing and producing process | |
| GB9417880D0 (en) | Vaccine | |
| HUT72403A (en) | Babesia vaccine | |
| GR3032256T3 (en) | Babesia vaccine | |
| GB9416667D0 (en) | Vaccines and diagnostics | |
| GB9503867D0 (en) | Vaccines and diagnostics | |
| GB9406708D0 (en) | Vaccines | |
| GB9320317D0 (en) | Vaccines and diagnostics | |
| GB9419969D0 (en) | Vaccine | |
| HU9400634D0 (en) | Vaccine and diagnosticum against parvovirosis of gooses and barbari duks | |
| ZA952370B (en) | Vaccines | |
| GB9405990D0 (en) | Vaccines | |
| GB9418058D0 (en) | Vaccines |